Why This 1 Value Stock Could Be a Great Addition to Your Portfolio
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Should You Invest in Tenet ( THC ) Based on Bullish Wall Street Views?
Based on the average brokerage recommendation (ABR), Tenet (THC) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
Encompass Health Q2 Earnings Beat Estimates, Stock Up 7.4%
EHC posts strong Q2 with higher EPS, revenue growth, and a raised 2025 outlook, along with shares gaining 7.4%.
Are Investors Undervaluing Tenet Healthcare ( THC ) Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Are Medical Stocks Lagging Arcutis Biotherapeutics ( ARQT ) This Year?
Here is how Arcutis Biotherapeutics, Inc. (ARQT) and Tenet Healthcare (THC) have performed compared to their sector so far this year.
Pediatrix Medical's Q2 Earnings Beat on Strong Patient Volumes
MD's Q2 earnings benefit from higher patient volumes and a declining expense level. It now projects 2025 adjusted EBITDA within $245-$255 million, up from the prior view of $220-$240 million.
Sila Realty ( SILA ) Q2 2025 Earnings Call Transcript
Image source: The Motley Fool.Thursday, Aug. 7, 2025, at 11 a.m. ETNeed a quote from a Motley Fool analyst? Email [email protected] reading ...
Select Medical Shares Down 20% Despite Q2 Earnings Beat
SEM beats Q2 EPS estimates on strong Rehab admissions and higher revenue per patient day. Yet, shares drop 20.4% post-earnings.
Zacks Investment Ideas feature highlights: CVS Health, Johnson & Johnson and Tenet Healthcare
CVS, JNJ, and Tenet Healthcare shine as defensive picks with strong earnings momentum and attractive valuations.
3 Medical Stocks to Consider as Markets Take a Breather
These top medical stocks may be able to provide defensive safety after President Trump's tariff hikes and July's unfavorable jobs report led to a market selloff.
Here's Why Tenet Healthcare ( THC ) is a Strong Value Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Tenet Healthcare Corporation ( THC ) Is a Trending Stock: Facts to Know Before Betting on It
Tenet (THC) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
HUM Misses Q2 Earnings on Higher Benefit Costs, Ups '25 EPS View
Humana's Q2 earnings fall year over year on a declining membership base. Notably, 2025 adjusted EPS is currently forecasted at around $17.00, up from the earlier view of around $16.25.
What Does the Market Think About Tenet Healthcare? - Tenet Healthcare ( NYSE:THC )
Tenet Healthcare's THC short percent of float has fallen 16.47% since its last report. The company recently reported that it has 2.92 million shares sold short, which is 4.16% of all regular shares that are available for trading.
Here's How Much You Would Have Made Owning Tenet Healthcare Stock In The Last 5 Years
Tenet Healthcare THC has outperformed the market over the past 5 years by 28.62% on an annualized basis producing an average annual return of 42.8%. Currently, Tenet Healthcare has a market capitalization of $14.56 billion.
ENSG's Q2 Earnings Beat on Higher Occupancy Rates, Stock Up 9%
Ensign Group's Q2 earnings improve 20.5% year over year, fueled by stronger occupancy, patient days and rental revenues.
Here's Why Tenet Healthcare ( THC ) is a Strong Growth Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Is It Worth Investing in Tenet ( THC ) Based on Wall Street's Bullish Views?
The average brokerage recommendation (ABR) for Tenet (THC) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
HCA Beats Q2 Earnings on Higher Admissions, Ups '25 EPS View
HCA Healthcare's Q2 earnings rose 24% year over year on stronger patient volumes. EPS for 2025 is expected to be within $25.5-$27, up from the earlier view of $24.05-$25.85.
Is Tenet Healthcare ( THC ) Stock Undervalued Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Down 14% in 4 Weeks, Here's Why You Should You Buy the Dip in Tenet ( THC )
Tenet (THC) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
New Strong Buy Stocks for July 25th
PHIN, MBWM, THC, RVLV and PHAR have been added to the Zacks Rank #1 (Strong Buy) List on July 25, 2025.
Best Value Stocks to Buy for July 25th
EDNMY, THC and MBWM made it to the Zacks Rank #1 (Strong Buy) value stocks list on July 25, 2025.
Molina Healthcare Stumbles; Cigna, CVS And Humana Go With It - Molina Healthcare ( NYSE:MOH )
Molina reported Q2 EPS of $5.48, below estimates of $6.21; revenue beat at $11.43 billion vs. $10.93 billion. Molina cut 2025 EPS outlook to over $19, down from $21.50-$22.50; MCR forecast at 90.2% Up Next: Get 5 Dark Horse Stocks Wall Street Is Quietly Loading Up On Molina Healthcare Inc.
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
Is the Options Market Predicting a Spike in Tenet Healthcare Stock?
Investors need to pay close attention to THC stock based on the movements in the options market lately.
$100 Invested In Tenet Healthcare 5 Years Ago Would Be Worth This Much Today - Tenet Healthcare ( NYSE:THC )
Tenet Healthcare THC has outperformed the market over the past 5 years by 29.5% on an annualized basis producing an average annual return of 44.08%. Currently, Tenet Healthcare has a market capitalization of $14.57 billion.
These Analysts Boost Their Forecasts On Tenet Healthcare After Upbeat Q2 Results - Tenet Healthcare ( NYSE:THC )
Tenet Healthcare Corporation THC posted better-than-expected earnings for the second quarter on Tuesday. The company reported quarterly earnings of $4.02 per share which beat the analyst consensus estimate of $2.87 per share.
Tenet Revenue Tops Estimates in Q2
Tenet Healthcare ( NYSE:THC ) , the healthcare operator with a large network of hospitals and ambulatory surgery centers, reported earnings for Q2 2025 on July 22, 2025. The most notable result: adjusted earnings per share ( EPS ) soared to $4.02 ( non-GAAP ) -- well above Wall Street ...
Tenet Beats Q2 Earnings on Strong Patient Volumes, Hikes '25 EPS View
THC's Q2 earnings benefit on the back of strong volumes, facility buyouts, higher acuity and favorable payer mix. It currently expects 2025 adjusted EPS within $15.55-$16.21, up from the earlier view of $11.99-$13.12.
Tenet ( THC ) Q2 2025 Earnings Call Transcript
Image source: The Motley Fool.Tuesday, July 22, 2025 at 10 a.m. ETChief Executive Officer - Saumya SutariaContinue reading ...
Danaher Q2 Earnings Beat Estimates, Life Sciences Sales Up Y/Y
DHR tops Q2 estimates with strong sales across segments, lifting its 2025 EPS outlook amid mixed margin trends.
Tenet Healthcare ( THC ) Beats Q2 Earnings and Revenue Estimates
Tenet (THC) delivered earnings and revenue surprises of +41.55% and +2.43%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks Industry Outlook Highlights HCA Healthcare, Tenet Healthcare, Universal Health and Community Health Systems
Despite industry pressures, HCA, THC, UHS, and CYH are leveraging M&A, tech, and rising demand to drive resilient growth.
HCA Healthcare to Report Q2 Earnings: Key Estimates to Note
The Zacks Consensus Estimate for HCA's Q2 EPS and revenues suggests a year-over-year upside despite higher costs and surgery volume pressure.
Hospital Market May Be Sick, But These 4 Stocks Are Healthy
HCA, THC, UHS, and CYH are showing strength through smart expansions and solid earnings despite hospital industry headwinds.
HCA Healthcare ( HCA ) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
HCA (HCA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Tenet Healthcare ( THC ) Rises Higher Than Market: Key Facts
Tenet Healthcare (THC) concluded the recent trading session at $175.14, signifying a +1.01% move from its prior day's close.
Insights Into Tenet ( THC ) Q2: Wall Street Projections for Key Metrics
Get a deeper insight into the potential performance of Tenet (THC) for the quarter ended June 2025 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for some of its key metrics.
Tenet Healthcare Corporation ( THC ) is Attracting Investor Attention: Here is What You Should Know
Zacks.com users have recently been watching Tenet (THC) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Why Tenet Healthcare ( THC ) is a Top Value Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
New study reveals shift in pediatric obesity treatment following AAP guidelines
BELLEVUE, Wash., July 14, 2025 ( GLOBE NEWSWIRE ) -- A groundbreaking study published today in Pediatrics Open Science shows a notable increase in the use of medication to treat pediatric obesity in the United States following the 2023 release of comprehensive guidelines by the American Academy ...
Why Tenet Healthcare ( THC ) is a Top Growth Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Tenet Healthcare ( THC ) Outpaces Stock Market Gains: What You Should Know
The latest trading day saw Tenet Healthcare (THC) settling at $173.66, representing a +1.32% change from its previous close.
Here's How Much $1000 Invested In Tenet Healthcare 15 Years Ago Would Be Worth Today - Tenet Healthcare ( NYSE:THC )
Tenet Healthcare THC has outperformed the market over the past 15 years by 3.5% on an annualized basis producing an average annual return of 15.79%. Currently, Tenet Healthcare has a market capitalization of $15.92 billion.
Is Tenet ( THC ) a Buy as Wall Street Analysts Look Optimistic?
The average brokerage recommendation (ABR) for Tenet (THC) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
What Does the Market Think About Tenet Healthcare? - Tenet Healthcare ( NYSE:THC )
Tenet Healthcare's THC short percent of float has risen 47.37% since its last report. The company recently reported that it has 4.13 million shares sold short, which is 5.88% of all regular shares that are available for trading.
Tenet Healthcare Corporation ( THC ) Is a Trending Stock: Facts to Know Before Betting on It
Zacks.com users have recently been watching Tenet (THC) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Tenet Healthcare ( THC ) Stock Dips While Market Gains: Key Facts
In the most recent trading session, Tenet Healthcare (THC) closed at $172.22, indicating a -2.94% shift from the previous trading day.
Will Tenet ( THC ) Beat Estimates Again in Its Next Earnings Report?
Tenet (THC) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
